Related Experiment Videos

Differences in cellular responses to mitogens in arterial smooth muscle cells derived from patients with moyamoya

M Yamamoto1, M Aoyagi, N Fukai

  • 1Department of Cell Biology, Tokyo Metropolitan Institute of Gerontology, Japan.

Stroke
|June 17, 1998
PubMed
Abstract

Insights

Smooth muscle cells (SMCs) from moyamoya disease patients show altered responses to growth factors, impacting intimal thickening. Interleukin-1 beta inhibits moyamoya SMC migration via a nitric oxide-independent pathway.

Area of Science:

  • Cerebrovascular diseases
  • Cell biology
  • Immunology

Background:

  • Moyamoya disease is a progressive cerebrovascular occlusive disease primarily affecting children.
  • The exact etiology of moyamoya disease remains unknown.
  • This study investigates the role of inflammatory cell products in moyamoya disease pathogenesis.

Purpose of the Study:

  • To examine the chemotactic and proliferative activities of arterial smooth muscle cells (SMCs) from moyamoya patients.
  • To compare these activities with those of SMCs from control subjects.
  • To elucidate the cellular mechanisms underlying intimal thickening in moyamoya disease.

Main Methods:

  • Utilized 12 SMC strains from moyamoya patients and 8 from control subjects.
  • Assessed SMC migration using a micro chemotaxis chamber.
  • Measured DNA synthesis via an immunoperoxidase technique.

Main Results:

  • Platelet-derived growth factor (PDGF)-BB stimulated migration and DNA synthesis in control SMCs, while PDGF-AA primarily stimulated DNA synthesis.
  • Moyamoya SMCs showed migration in response to both PDGF-AA and PDGF-BB but not increased DNA synthesis.
  • Interleukin-1 beta (IL-1 beta) stimulated migration and DNA synthesis in control SMCs but inhibited moyamoya SMC migration through a nitric oxide-independent pathway.

Conclusions:

  • Differential responses of moyamoya SMCs to PDGF and IL-1 are implicated in the intimal thickening characteristic of moyamoya disease.
  • The findings suggest a novel mechanism involving inflammatory responses in moyamoya disease progression.
  • Further research into these cellular mechanisms could lead to targeted therapies.

Related Concept Videos